MSACL 2018 US Abstract Title:
Mass Spectrometry Imaging Enables Molecular Diagnosis of Melanocytic Lesions
Erin Seeley
Protea Biosciences

Description Y/N Source
Grants no

Salary no

Board Member no

Stock no

Expenses yes Expenses paid by Protea Biosciences

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:
no

Description	Y/N	Source
Grants	no
Salary	no
Board Member	no
Stock	no
Expenses	yes	Expenses paid by Protea Biosciences